Industry

DUBLIN–(BUSINESS WIRE)–The “Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence … [Read more…]

MILPITAS, Calif.–(BUSINESS WIRE)–#Bioproduction–Applied StemCell, Inc. (ASC), a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products, today announced the expansion of its Current Good Manufacturing (cGMP) facility. ASC has successfully carried out cell banking and product manufacturing projects … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Teva Pharmaceuticals has notified MedinCell (Paris:MEDCL) that it made the decision to initiate the clinical Phase 3 trial for mdc‑TJK. MedinCell will receive immediately a $3 million payment from Teva Pharmaceuticals linked to the project development milestone. The Phase 3 study will assess the efficacy and safety of potentially the first subcutaneous long-acting … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Primary Ciliary Dyskinesia – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. The Primary Ciliary Dyskinesia market report provides current treatment practices, emerging drugs, Primary Ciliary Dyskinesia market share of the individual therapies, current and forecasted Primary Ciliary Dyskinesia market Size from 2019 to 2032 segmented by … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. The Skin And Skin Structure Infections (SSSI) Caused By Bacteria market report provides current treatment practices, emerging drugs, Skin And Skin Structure Infections (SSSI) Caused By Bacteria market share … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pulse Oximeter Market Research Report by Type (Fingertip Pulse Oximeter and Handheld Pulse Oximeter), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Pulse Oximeter Market size was estimated at USD 2,477.41 … [Read more…]

A team of scientists at Institute of Protein Design led by David Baker, Ph.D., and ARCH Venture Partners launch Vilya to create a new transformational class of medicines Paper published today in Cell describes the ground-breaking research behind Vilya’s foundational technology leveraging advanced computational approaches to design novel molecules, never before found in nature, with … [Read more…]

The Company strengthens its healthy foods benefit offering to health plans by advancing post-discharge meal capabilities and expanding meal offerings. FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#DeliverLean–NationsBenefits®, a leading provider of supplemental benefits, flex cards, and member engagement solutions for health plans, announced today an agreement to acquire DeliverLean™, one of the country’s largest food manufacturers specializing in … [Read more…]

Conference to Connect Medtech Leaders at the Forefront of Healthcare Innovation STANFORD, Calif.–(BUSINESS WIRE)–MedtechWomen today announced its tenth annual MedtechVision Conference, designed by and for women at the forefront of medical innovation. The conference, which is presented by MedtechWomen in partnership with Stanford Byers Center for Biodesign, will be held on Friday, September 9, 2022 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fatty Acid Amide Hydrolase (FAAH) Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Fatty Acid Amide Hydrolase (FAAH) Inhibitor – Pipeline Insight, 2022” report by the publisher offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Fatty Acid Amide Hydrolase (FAAH) Inhibitor development. … [Read more…]